Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid
JK has received honoraria from Bristol-Myers Squibb, UCB, Sun Pharma, Sanofi, Novartis, Beiersdorf AG, doctorderma Online Hautarzt and Melatech, outside the submitted work. JK has received travel support from SUN Pharma and Pierre Fabre, outside the submitted work. FA and IHA received speaker fees from Sanofi, outside the submitted work. The other authors declare no conflict of interest.
Authors
- Jana Bertels (ORCID: https://orcid.org/0009-0000-9123-6315)
- Julian Kött (ORCID: https://orcid.org/0000-0003-2073-3909)
- Finn Abeck (ORCID: https://orcid.org/0000-0001-7823-0736)
- Inga Hansen (ORCID: https://orcid.org/0009-0007-5579-4337)
- Nina Matthes (ORCID: https://orcid.org/0009-0004-9004-1881)
- Stefan W. Schneider
- Nina Booken
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2026-05-08
- DOI
- https://doi.org/10.1111/ddg.70397
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00